评估老年人潜在不合适药物使用的工具:评估适用于注册研究的范围审查
Katrine Mose1, Carina Lundby1,2, Lotte Rasmussen1
1Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Basic & clinical pharmacology & toxicology
|September 4, 2025
概括
这一审查确定了评估老年人不适当处方的工具,并突出了那些适用于基于登记册的研究的工具. 由于最低数据要求,欧洲清单,普里斯库斯,Zhan和挪威标准是理想的.
科学领域:
- 老年人药理学
- 医疗服务研究
- 药物的安全性
背景情况:
- 在老年人中,潜在不合适的处方 (PIP) 是一个重大问题.
- 评估PIP对于改善健康结果和降低医疗保健成本至关重要.
- 现有的工具在数据要求和适用于不同研究环境方面有所不同.
研究的目的:
- 提供用于评估老年人可能不合适的处方工具的概述.
- 评估这些工具是否适用于基于登记的研究.
- 引导研究人员选择适合他们的研究工具.
主要方法:
- 在PubMed (2024年3月) 系统搜索相关研究.
- 纳入标准:评估65岁或以上成年人PIP的研究.
- 基于特征,使用频率和基于登记册的数据需求的确定工具的分析.
主要成果:
- 确定了419项研究,使用了44种不同的工具.
- 酒标准 (50%) 和老年人处方选工具 (19%) 是最常用的.
- 四个工具 (欧洲名单,PRISCUS,Zhan,挪威通用实践) 需要最小的临床数据,从而提高它们对基于登记的研究的有用性.
结论:
- 有几种工具可用于评估老年人可能不合适的处方.
- 需要较少临床数据的工具对于基于登记的研究尤为有利.
- 在选择评估工具时,数据的可用性是确保有效和有意义的结果的关键因素.
更多相关视频
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.3K
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
6.8K
相关概念视频
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
